 |
| About Bioline | All Journals | Testimonials | Membership | News |
|
||||||
|
||||||
Indian Journal of Pharmacology, Vol. 43, No. 2, March-April, 2011, pp. 220-221 Letter to Editor Dysmorphic child born after maternal diclofenac therapy Syed Ahmed Zaki1, Angadi Rajasab Nilofer2, Preeti Shanbag1 1 Department of Pediatrics, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, India Correspondence Address: Syed Ahmed Zaki, Room no 509, New RMO quarters, Shastri Galli, Sion, Mumbai - 22, India, drzakisyed@gmail.com Code Number: ph11061 DOI: 10.4103/0253-7613.77385 Sir, A five-month-old baby was brought with complaints of abnormal facial features. A detailed birth and past history revealed that the baby was the third child, born of a non-consanguineous marriage. The mother was prescribed tablet diclofenac sodium (100 mg thrice daily) by a general practitioner for joint pain during the first trimester of pregnancy. The joint pain disappeared after four days. However, she continued taking tablet diclofenac on her own. There was no significant antenatal history suggestive of systemic disease. She delivered a full-term baby boy, with a birth weight of 2.25 kg, and was discharged on breast feeds on the second postnatal day. After three months an echocardiography was done in view of recurrent lower respiratory tract infections. It showed a 4.5 mm non-restrictive patent ductus arteriosus (left to right), 4 mm atrial septal defect (left to right), and severe pulmonary artery hypertension. On examination, the head circumference was 41 cm., weight was 3.1 kg, and length was 58 cm (below the fifth percentile for age and gender), suggestive of failure to thrive. Dysmorphic facies were present in the form of low set and deformed external ears. Oral cavity examination revealed a high arched palate. He also had hypertelorism and wide spaced nipples [Figure - 1]. Serologic tests for toxoplasma, rubella, cytomegalovirus, and herpes simplex were negative. The complete blood count, ultrasound of the skull, and chromosomal analysis was normal. Ultrasound of the abdomen showed absent left kidney. Family history revealed that the other siblings were normal, without any dysmorphic facies or systemic abnormality.With a history of maternal intake of diclofenac during early pregnancy and normal family history, it can be postulated that a high dose diclofenac could have been responsible for the multiple anomalies seen in this patient. This can be considered as a possible adverse drug reaction as per causality assessment, on Naranjo′s scale. Diclofenac is a non-steroidal, anti-inflammatory drug, widely prescribed in India to women of child bearing age for the treatment of various conditions, including arthritis, musculo-skeletal pain, dysmenorrhea, and menorrhagia. The primary mechanism responsible for its action is inhibition of prostaglandin synthesis via the cyclo-oxygenase enzyme. [1] It is placed under ′category C′ in the ′United States Food and Drug Administration′ classification of the pregnancy categories for pharmaceuticals. [2] Even though conclusive evidence about the teratogenecity of diclofenac in human embryos is lacking, animal studies have shown that administration of the drug at a high concentration, in early gestation, inhibits implantation and embryonic development. [1] It crosses the human placenta readily during the first trimester and should be considered as potentially teratogenic. [3] Ventricular septal defect and aplasia cutis congenita have been reported in babies born to mothers on diclofenac therapy. [4],[5] The drug is known to accumulate in the fetal tissue with time. It is usually prescribed in multiple doses, thereby resulting in a high probability of fetal tissue concentration reaching the teratogenic level. [1] The exact mechanism of diclofenac-induced teratogenecity is uncertain. It may result from free oxygen radical damage to the developing embryo. Also, it has been postulated that by inhibiting the synthesis of vasodilatory prostaglandins, diclofenac can cause transient vasoconstriction and decreased blood supply, resulting in malformation and cellular death. Acknowledgement We would like to thank Dr. Sandhya Kamath, Dean of our institution, for permitting us to publish this manuscript. References
Copyright 2011 - Indian Journal of Pharmacology The following images related to this document are available:Photo images[ph11061f1.jpg] |
| |||||||||
![[Figure - 1]](/showimage?ph/photo/ph11061f1.jpg){kind=link}